Data as of Apr 17
| +0.44 / +2.86%|
The 2 analysts offering 12-month price forecasts for Repligen Corp have a median target of 16.50, with a high estimate of 17.00 and a low estimate of 16.00. The median estimate represents a +4.17% increase from the last price of 15.84.
The current consensus among 2 polled investment analysts is to Buy stock in Repligen Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.